Jon Erlendsson Selected Research

Jon Erlendsson Research Topics

3	Inflammation (Inflammations) 12/2011 - 06/2010
2	Necrosis 08/2011 - 06/2010
2	Ankylosing Spondylitis 08/2011 - 10/2004
1	Spondylarthritis (Spinal Arthritis) 12/2011
1	Axial Spondyloarthritis 08/2011
1	Wounds and Injuries (Trauma) 10/2004

3	C-Reactive ProteinIBA 12/2011 - 06/2010
2	Cartilage Oligomeric Matrix ProteinIBA 12/2011 - 08/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 06/2010
2	Biomarkers (Surrogate Marker)IBA 12/2011 - 08/2011
2	OsteocalcinIBA 12/2011 - 08/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2011 - 08/2011
2	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 12/2011 - 08/2011
2	Matrix Metalloproteinases (MMPs)IBA 12/2011 - 08/2011
2	Collagen Type II (Type II Collagen)IBA 12/2011 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 08/2011
2	Aggrecans (Aggrecan)IBA 12/2011 - 08/2011
1	Collagen Type I (Type I Collagen)IBA 08/2011
1	Adalimumab (Humira)FDA Link 06/2010
1	Infliximab (Remicade)FDA Link 06/2010
1	Etanercept (Enbrel)FDA Link 06/2010
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2004

3	Therapeutics 12/2011 - 10/2004